Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Muscle skeletal receptor tyrosine-protein kinase MuSK (MUSK) is a receptor tyrosine kinase that plays an essential role in the formation, maintenance, and function of the neuromuscular junction (NMJ), which is the synapse between motor neurons and skeletal muscle fibers. Activation occurs when neuronal agrin binds to LRP4 on muscle cells; this complex then activates MuSK via phosphorylation. Mutations or autoantibodies against MuSK can cause or contribute to disease, like Congenital myasthenic syndromes and Myasthenia gravis.
Not applicable, direct inhibitors/activators not mentioned, but targeting via associated molecules like Agrin or LRP4 is possible.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscle skeletal receptor tyrosine-protein kinase MuSK (MUSK).